Latest Headlines

  1. MKS Announces Ophir® Laser Power Sensors With Very High Damage Threshold, Very Low Reflection

    Munich, Germany - MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, has announced a new line of high damage threshold laser power/energy sensors designed for CW lasers with high power densities, as well as long as for pulse lasers. The Ophir® 1000W-LP2-34, L1500W-LP2-50, 5000W-LP2-50, and FL600A-LP2-65 feature a new LP2 coating that provides the highest damage threshold in the industry, 10kW/cm2 at 1kW power.  

  2. Researchers Develop Microneedle Patch For Flu Vaccination

    A National Institutes of Health-funded study led by a team at the Georgia Institute of Technology and Emory University has shown that an influenza vaccine can produce robust immune responses and be administered safely with an experimental patch of dissolving microneedles.

  3. J&J’s Depuy Synthes Acquires Spinal Nerve Localization Tech Developer Sentio

    DePuy Synthes Products, Inc., part of the Johnson & Johnson Medical Devices Companies*, announced today that it has acquired Innovative Surgical Solutions, LLC, doing business as Sentio, LLC, a privately-held company based in Wixom, Michigan that markets innovative nerve localization technology for spine surgery.

  4. FDA Clears Philips’ Ninth Version Of IntelliSpace Portal Image Analytics Platform

    Royal Philips, a global leader in health technology, recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market IntelliSpace Portal 9.0 and a range of innovative applications for Radiology in the U.S.

  5. Medtronic, Aetna Ink Agreement That Ties Insulin Pump Payment To Patient Outcomes

    Medtronic plc, the global leader in medical technology, recently announced a new outcomes-based agreement with Aetna for type 1 and type 2 diabetes patients currently on multiple daily insulin injections for their diabetes management.

  6. Philips Releases Intellivue X3 Monitor In Europe

    Royal Philips (NYSE: PHG AEX: PHIA), a global health technology company, today announced the release of the IntelliVue X3 in Europe.

  7. Philips To Acquire Brain Monitoring Company Electrical Geodesics, Inc.

    Royal Philips , a global leader in health technology, recently announced an agreement to acquire Electrical Geodesics, Inc. (EGI), a US-based medical device company that designs, develops and commercializes a range of non-invasive technologies used to monitor and interpret brain activity. EGI’s portfolio of EEG hardware, software and acquisition sensors will complement Philips’ existing portfolio of imaging technologies (e.g. MRI and PET-CT) and advanced informatics (e.g. IntelliSpace Portal) for neurological applications.

  8. FDA Grants Merit Medical’s Embosphere Microspheres de novo Classification For Prostatic Artery Embolization)

    Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has received 513(f)(2) (de novo) classification from the FDA to expand indication for Merit’s Embosphere® Microspheres.


  9. FDA Clears First RF Ablation Treatment For Osteoarthritis Knee Pain

    The U.S. Food and Drug Administration (FDA) has approved the first and only radio frequency (RF) treatment to be cleared specifically to alleviate chronic knee pain due to osteoarthritis.

  10. Medron Expands Thermoplastic Extrusion Capabilities

    The subsidiary of Flexan L.L.C. has hired Clarence Williams as its vice president of thermoplastics extrusion services and, in a joint move, is investing to add two new extrusion lines at its Salt Lake City site to rehouse thermoplastic extrusion production.